Shuzhen Wang
Publications by Year
Research Areas
Retinal Development and Disorders, PI3K/AKT/mTOR signaling in cancer, Genomics and Phylogenetic Studies, Ovarian cancer diagnosis and treatment, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19(2020)5,500 cited
- → Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial(2020)3,652 cited
- → Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma(2013)1,114 cited
- → Single Image Super-Resolution via a Holistic Attention Network(2020)657 cited
- → Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice(2012)201 cited
- → A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia(2021)191 cited
- → Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells(2011)183 cited
- → Heart Rate Variability Biofeedback Decreases Blood Pressure in Prehypertensive Subjects by Improving Autonomic Function and Baroreflex(2012)138 cited
- → Proteomic identification of OsCYP2, a rice cyclophilin that confers salt tolerance in rice (Oryza sativa L.) seedlings when overexpressed(2011)133 cited
- → Biodegradable Drug-Loaded Hydroxyapatite Nanotherapeutic Agent for Targeted Drug Release in Tumors(2018)130 cited